Status:
COMPLETED
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
Lead Sponsor:
Lene Holmvang
Conditions:
Coronary Artery Disease
Percutaneous Coronary Intervention
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
All patients undergoing elective or sub-acute PCI are screened by MULTIPLATE test for clopidogrel low-responsiveness after receiving 600 mg clopidogrel the day before. A cut off value has previously ...
Eligibility Criteria
Inclusion
- PCI with stenting and Multiplate hep-ADP \> 70 U despite clopidogrel loading
Exclusion
- need for vit K antagonist
- women with childbearing potential
- breastfeeding women
- Planned surgery within 6 months
- Intolerance to clopidogrel, prasugrel or aspirin
- previous stroke
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT01135667
Start Date
September 1 2010
End Date
August 1 2012
Last Update
October 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Department of Cardiology, 2013
Copenhagen O, Denmark, 2100